Y. Fernández

Gradual reduction of testosterone using a gonadotropin-releasing hormone vaccination delays castration resistance in a prostate cancer model.

R. Bringas, R. Millar, G. Guillén, 2016, Oncology letters.

Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac

R. Bringas, G. Guillén, L. E. Fernández, 2019, Front. Oncol..